CD4 and lymphopenia: ▪In HSCT, primary prophylaxis with letermovir, which may also serve as secondary prophylaxis in high-risk patients [105]▪As PWH undergoing HSCT may have an increased risk of developing CMV reactivation, primary prophylaxis may be indicated for longer periods with prolonged immunosuppression or CD4+ lymphopenia.